The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
Abstract
Understanding cellular response to environmental stress has broad implications for human disease. AMP-activated protein kinase (AMPK) orchestrates the regulation of energy-generating and -consuming pathways, and protects the heart against ischaemic injury and apoptosis. A role for circulating hormones such as adiponectin and leptin in the activation of AMPK has received recent attention. Whether local autocrine and paracrine factors within target organs such as the heart modulate AMPK is unknown. Here we show that macrophage migration inhibitory factor (MIF), an upstream regulator of inflammation, is released in the ischaemic heart, where it stimulates AMPK activation through CD74, promotes glucose uptake and protects the heart during ischaemia-reperfusion injury. Germline deletion of the Mif gene impairs ischaemic AMPK signalling in the mouse heart. Human fibroblasts with a low-activity MIF promoter polymorphism have diminished MIF release and AMPK activation during hypoxia. Thus, MIF modulates the activation of the cardioprotective AMPK pathway during ischaemia, functionally linking inflammation and metabolism in the heart. We anticipate that genetic variation in MIF expression may impact on the response of the human heart to ischaemia by the AMPK pathway, and that diagnostic MIF genotyping might predict risk in patients with coronary artery disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanically, AMPK increased glucose uptake and glucose transporter 4 translocation [171], decreased apoptosis, improved post-ischemic recovery, and limited myocardial infarction (MI) [172,173].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [171]
Citations
Cites
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Bernhagen, J., Krohn, R. M., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,292
Self-citationMIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
Self-citationMIF as a glucocorticoid-induced modulator of cytokine production
Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T. M., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,148
Self-citationThe Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., & Bucala, R. (1993) · Nature · doi:10.1038/365756a0 · Cited by 1,001
Self-citationCalandra, T., Bernhagen, J., Mitchell, R. A., & Bucala, R. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.6.1895 · Cited by 986
Self-citationShibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., & Walsh, K. (2005) · Nature Medicine · doi:10.1038/nm1295 · Cited by 982
Marsin, A.-S., Bertrand, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent, M. F., den Berghe, G. V., Carling, D., & Hue, L. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00742-9 · Cited by 853
Cited by
Sorted by citations
Ischemia and reperfusion—from mechanism to translation
Eltzschig, H. K., & Eckle, T. D. L. G. (2011) · Nature Medicine · doi:10.1038/nm.2507 · Cited by 3,468
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Zhang, B. B., Zhou, G., & Li, C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.012 · Cited by 1,042
Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Re, D. P. D., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 994
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 782
Self-citationMicroRNA-451 Regulates LKB1/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells
Godlewski, J. A., Nowicki, M. O., Bronisz, A., Nuovo, G. J., Palatini, J., Lay, M. D. D., Brocklyn, J. R. V., Ostrowski, M. C., Chiocca, E. A., & Lawler, S. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.018 · Cited by 426
Ma, H., Guo, R., Yu, L., Zhang, Y., & Ren, J. T. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq253 · Cited by 335
The biological function and significance of CD74 in immune diseases
Su, H., Na, N., Zhang, X., & Zhao, Y. X. (2016) · Inflammation Research · doi:10.1007/s00011-016-0995-1 · Cited by 309
Sumaiya, K., Langford, D., Natarajaseenivasan, K., & Shanmughapriya, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108024 · Cited by 317
AMPK as a mediator of hormonal signalling
Lim, C. T., Kola, B., & Korbonits, M. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0063 · Cited by 304
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
Döring, Y., Pawig, L., Weber, C., & Noels, H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00212 · Cited by 293
AMPK: energy sensor and survival mechanism in the ischemic heart
Qi, D., & Young, L. H. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.05.010 · Cited by 287
Self-citationAMPK, Mitochondrial Function, and Cardiovascular Disease
Wu, S., & Zou, M.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144987 · Cited by 286
Macrophage Migration Inhibitory Factor in Cardiovascular Disease
Zernecke, A., Bernhagen, J., & Weber, C. (2008) · Circulation · doi:10.1161/circulationaha.107.729125 · Cited by 277
AMP-activated protein kinase regulation and biological actions in the heart
Zaha, V. G., & Young, L. H. (2012) · Circulation Research · doi:10.1161/circresaha.111.255505 · Cited by 279
Self-citationThe immunobiology of MIF: function, genetics and prospects for precision medicine
Kang, I., & Bucala, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0238-2 · Cited by 263
Self-citationAshabi, G., Khalaj, L., Khodagholi, F., Goudarzvand, M., & Sarkaki, A. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9632-2 · Cited by 258
Evolving complexity of MIF signaling
Jankauskas, S. S., Wong, D. W. L., Bucala, R., Djudjaj, S., & Boor, P. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.01.006 · Cited by 246
Self-citationMerk, M., Zierow, S., Leng, L., Das, R., Du, X., Schulte, W., Fan, J., Lue, H., Chen, Y., Xiong, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102941108 · Cited by 243
Self-citationAMPK: Potential Therapeutic Target for Ischemic Stroke
Jiang, S., Li, T. X., Ji, T., Yi, W., Yang, Z. P., Wang, S., Yang, Y., & Gu, C. (2018) · Theranostics · doi:10.7150/thno.25674 · Cited by 256
Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
Andreadou, I., Cabrera-Fuentes, H. A., Devaux, Y., Frangogiannis, N. G., Frantz, S., Guzik, T. J., Liehn, E. A., Gomes, C. P. C., Schulz, R., & Hausenloy, D. J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz050 · Cited by 214
Kuwabara, Y., Horie, T., Baba, O., Watanabe, S., Nishiga, M., Usami, S., Izuhara, M., Nakao, T., Nishino, T., Otsu, K., et al. (2014) · Circulation Research · doi:10.1161/circresaha.116.304707 · Cited by 214
Pawig, L., Klasen, C., Weber, C., Bernhagen, J., & Noels, H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00429 · Cited by 229
Hiress, M. L., Tu, L., Ricard, N., Phan, C., Thuillet, R., Fadel, É., Dorfmüller, P., Montani, D., de Man, F. S., Humbert, M. J. C., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0322oc · Cited by 212
Beauloye, C., Bertrand, L., Horman, S., & Hue, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr034 · Cited by 191
Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models
Ogura, Y., Ouchi, N., Ohashi, K., Shibata, R., Kataoka, Y., Kambara, T., Kito, T., Maruyama, S., Yuasa, D., Matsuo, K., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.115089 · Cited by 183
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Timm, K. N., & Tyler, D. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06941-x · Cited by 192
Liu, H., Wu, X., Luo, J., Zhao, L., Li, X., Guo, H., Bai, H., Cui, W., Guo, W., Feng, D., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113302 · Cited by 179
Kataoka, Y., Shibata, R., Ohashi, K., Kambara, T., Enomoto, T., Uemura, Y., Ogura, Y., Yuasa, D., Matsuo, K., Nagata, T., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.032 · Cited by 174
Hardie, D. G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390001 · Cited by 180
Zhu, W., Sun, L. V., Zhao, P., Liu, Y., Zhang, J., Zhang, Y., Hong, Y., Zhu, Y., Lu, Y., Zhao, W., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00808-5 · Cited by 177
Qi, D., Hu, X., Wu, X., Merk, M., Leng, L., Bucala, R., & Young, L. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39738 · Cited by 174
Self-citationA small molecule AMPK activator protects the heart against ischemia–reperfusion injury
Kim, A. S., Miller, E. J., Wright, T. M., Li, J., Qi, D., Atsina, K. B.-T., Zaha, V. G., Sakamoto, K., & Young, L. H. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.003 · Cited by 176
Self-citationTachibana, A., Santoso, M. R., Mahmoudi, M., Shukla, P., Wang, L., Bennett, M. V., Goldstone, A. B., Wang, M., Fukushi, M., Ebert, A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310803 · Cited by 169
Chen, K., Li, G., Geng, F., Zhang, Z., Li, J., Yang, M. H., Dong, L., & Gao, F. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0977-0 · Cited by 168
Self-citationSestrin2 promotes LKB1‐mediated AMPK activation in the ischemic heart
Morrison, A., Chen, L., Wang, J., Zhang, M., Yang, H. M., Ma, Y., Budanov, A. V., Lee, J. H., Karin, M., & Li, J. (2014) · The FASEB Journal · doi:10.1096/fj.14-258814 · Cited by 169
Self-citationRole of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair
Farr, L., Ghosh, S., & Moonah, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01273 · Cited by 166
Ma, H., Wang, J., Thomas, D. P., Tong, C., Leng, L., Wang, W., Merk, M., Zierow, S., Bernhagen, J., Ren, J., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.953208 · Cited by 164
Self-citationEffects of AMP-Activated Protein Kinase in Cerebral Ischemia
Li, J., & McCullough, L. D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.255 · Cited by 165
Self-citationHypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 162
Ko, H. J., Zhang, Z., Jung, D. Y., Jun, J. Y., Ma, Z., Jones, K. E., Chan, S. Y., & Kim, J. K. (2009) · Diabetes · doi:10.2337/db08-1361 · Cited by 160
Heinrichs, D., Knauel, M., Offermanns, C., Berres, M., Nellen, A., Leng, L., Schmitz, P., Bucala, R., Trautwein, C., Weber, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107023108 · Cited by 156
Self-citationDixit, V. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108028 · Cited by 163
Role of the energy sensor AMP-activated protein kinase in renal physiology and disease
Hallows, K. R., Mount, P. F., Pastor‐Soler, N. M., & Power, D. A. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00005.2010 · Cited by 158
Repair After Myocardial Infarction, Between Fantasy and Reality
Liehn, E. A., Postea, O., Curaj, A., & Marx, N. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.034 · Cited by 157
Optimization of Cardiac Metabolism in Heart Failure
Nagoshi, T., Yoshimura, M., Rosano, G. M. C., Lopaschuk, G. D., & Mochizuki, S. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798357773 · Cited by 151
Verschuren, L., Kooistra, T., Bernhagen, J., Voshol, P. J., Ouwens, D. M., van Erk, M., der Weij, J. D. V.-V., Leng, L., van Bockel, J. H., van Dijk, K. W., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199166 · Cited by 147
Self-citationEnergy sensing by the AMP-activated protein kinase and its effects on muscle metabolism
Hardie, D. G. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110003915 · Cited by 146
Chemokines as Therapeutic Targets in Cardiovascular Disease
Noels, H., Weber, C., & Koenen, R. R. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312037 · Cited by 144
Simons, D., Grieb, G., Hristov, M., Pallua, N., Weber, C., Bernhagen, J., & Steffens, G. C. M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01041.x · Cited by 142
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
Chen, L., Zhou, X., Fan, L. X., Yao, Y., Swenson-Fields, K. I., Gadjeva, M. G., Wallace, D. P., Peters, D. J. M., Yu, A. S. L., Grantham, J. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80467 · Cited by 139
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
Shimano, M., Ouchi, N., Nakamura, K., van Wijk, B., Ohashi, K., Asaumi, Y., Higuchi, A., Pimentel, D. R., Sam, F., Murohara, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108559108 · Cited by 136
Dasgupta, B., & Milbrandt, J. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.005 · Cited by 136
The Golgi-Associated Protein p115 Mediates the Secretion of Macrophage Migration Inhibitory Factor
Merk, M., Baugh, J. A., Zierow, S., Leng, L., Pal, U., Lee, S. J., Ebert, A., Mizue, Y., Trent, J. O., Mitchell, R. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803710 · Cited by 127
Self-citationKoga, K., Kenessey, Á., Powell, S. R., Sison, C. P., Miller, E. J., & Ojamaa, K. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3163 · Cited by 125
Self-citationQuan, N., Sun, W., Wang, L., Xu, C., Bogan, J. S., Zhou, X., Cates, C. A., Liu, Q., Zheng, Y., & Li, J. (2017) · The FASEB Journal · doi:10.1096/fj.201700063r · Cited by 124
Self-citationwang, L., Quan, N., Sun, W., Chen, X., Cates, C. A., Rousselle, T. V., Zhou, X., Zhao, X., & Li, J. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy033 · Cited by 124
Self-citationImpaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress
Tong, C., Morrison, A., Mattison, S., Qian, S., Bryniarski, M. A., Rankin, B., Wang, J., Thomas, D. P., & Li, J. (2012) · The FASEB Journal · doi:10.1096/fj.12-216473 · Cited by 124
Self-citationAMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation
Daskalopoulos, E. P., Dufeys, C., Bertrand, L., Beauloye, C., & Horman, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.001 · Cited by 121
AMPK: a therapeutic target of heart failure—not only metabolism regulation
Li, X., Liu, J., Lü, Q., Ren, D., Sun, X., Rousselle, T. V., Tan, Y., & Li, J. (2018) · Bioscience Reports · doi:10.1042/bsr20181767 · Cited by 122
Self-citationThe cardiokine story unfolds: ischemic stress-induced protein secretion in the heart
Doroudgar, S., & Glembotski, C. C. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.003 · Cited by 117
Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems
Song, P., & Zou, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.025 · Cited by 122
Cardiokines: recent progress in elucidating the cardiac secretome
Shimano, M., Ouchi, N., & Walsh, K. (2012) · Circulation · doi:10.1161/circulationaha.112.150656 · Cited by 116
Liu, Z., Chen, J., Huang, H., Kuznicki, M. L., Zheng, S., Sun, W., Quan, N., Wang, L., Yang, H. M., Guo, H.-M., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.022 · Cited by 114
Self-citationStoppe, C., Averdunk, L., Goetzenich, A., Soppert, J., Marlier, A., Kraemer, S., Vieten, J., Coburn, M., Kowark, A., Kim, B., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4886 · Cited by 113
Self-citationGao, X., Liu, Y., White, D., Su, Y., Drew, B. G., Bruce, C. R., Kiriazis, H., Xu, Q., Jennings, N. L., Bobik, A., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.022 · Cited by 112
Self-citationArrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis
Tillmann, S., Bernhagen, J., & Noels, H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00115 · Cited by 113
Control of p53 and NF-κB signaling by WIP1 and MIF: Role in cellular senescence and organismal aging
Salminen, A., & Kaarniranta, K. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.012 · Cited by 111
Ohta, S., Misawa, A., Fukaya, R., Inoue, S., Kanemura, Y., Okano, H., Kawakami, Y., & Toda, M. (2012) · Journal of Cell Science · doi:10.1242/jcs.102210 · Cited by 110
Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
Ho, M.-Y., & Wang, C. (2021) · Cells · doi:10.3390/cells10082103 · Cited by 114
Wang, J., Ma, H., Tong, C., Zhang, H., Lawlis, G. B., Li, Y., Zang, M., Ren, J. T., Nijland, M. J., Ford, S. P., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-142315 · Cited by 109
Self-citationNerstedt, A., Johansson, A., Andersson, C. X., Cansby, E., Smith, U., & Mahlapuu, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1856-z · Cited by 106
Günther, S., Fagone, P., Jalce, G., Atanasov, A. G., Guignabert, C., & Nicoletti, F. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.003 · Cited by 105
Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway
Lü, Q., Liu, J., Li, X., Sun, X., Zhang, J., Ren, D., Tong, N., & Li, J. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110642 · Cited by 107
Self-citationThe vascular biology of macrophage migration inhibitory factor (MIF)
Asare, Y., Schmitt, M. M. N., & Bernhagen, J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-11-0831 · Cited by 100
AMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 114
Sinitski, D., Kontos, C., Krammer, C., Asare, Y., Kapurniotu, A., & Bernhagen, J. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1677803 · Cited by 97
AMP‐activated protein kinase: a core signalling pathway in the heart
Kim, A. S., Miller, E. J., & Young, L. H. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01978.x · Cited by 99
Self-citationXu, X., Hua, Y., Nair, S., Bucala, R., & Ren, J. T. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02219 · Cited by 97
Self-citationInácio, A. R. L., Ruscher, K., Leng, L., Bucala, R., & Deierborg, T. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.194 · Cited by 97
Self-citationTLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons
Shintani, Y., Kapoor, A., Kaneko, M., Smolenski, R. T., D’Acquisto, F., Coppen, S. R., Harada‐Shoji, N., Lee, H. J., Thiemermann, C., Takashima, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219243110 · Cited by 98
Zhang, Y., Zhu, W., He, H., Fan, B., Deng, R., Hong, Y., Liang, X., Zhao, H., Li, X., & Zhang, F. (2019) · Aging · doi:10.18632/aging.102592 · Cited by 93
Hartman, M. H. T., Groot, H. E., Leach, I. M., Karper, J. C., & van der Harst, P. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.02.003 · Cited by 93
Current developments of macrophage migration inhibitory factor (MIF) inhibitors
Xu, L., Li, Y., Sun, H., Zhen, X., Qiao, C., Tian, S., & Hou, T. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.12.013 · Cited by 92
Cardioprotection Through S -Nitros(yl)ation of Macrophage Migration Inhibitory Factor
Luedike, P., Hendgen-Cotta, U. B., Sobierajski, J., Totzeck, M., Reeh, M., Dewor, M., Lue, H., Krisp, C., Wolters, D. A., Kelm, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.069104 · Cited by 90
The Fire Within: Cardiac Inflammatory Signaling in Health and Disease
Coggins, M. P., & Rosenzweig, A. (2012) · Circulation Research · doi:10.1161/circresaha.111.243196 · Cited by 93
WANG, J., YANG, L., Rezaie, A. R., & Li, J. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04331.x · Cited by 88
Self-citationDuan, C., Kuang, L., Xiang, X., Zhang, J., Zhu, Y., Wu, Y., Yan, Q., Liu, L., & Li, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2461-9 · Cited by 88
Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias, and preconditioning
Özcan, C., Palmeri, M., Horváth, T. L., Russell, K. S., & Russell, R. R. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00592.2012 · Cited by 86
Morrison, A., Yan, X., Tong, C., & Li, J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00137.2011 · Cited by 87
Self-citationSalminen, A., Kaarniranta, K., & Kauppinen, A. (2016) · Biogerontology · doi:10.1007/s10522-016-9655-7 · Cited by 89
Xia, W., Zhang, F., Xie, C., Jiang, M., & Hou, M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0076-3 · Cited by 85
The Multitasking Potential of Alarmins and Atypical Chemokines
Kapurniotu, A., Gökçe, Ö., & Bernhagen, J. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00003 · Cited by 85
Wang, J., Tong, C., Yan, X., Yeung, E., Gandavadi, S., Hare, A. A., Du, X., Chen, Y., Xiong, H., Ma, C., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000862 · Cited by 85
Self-citationMacrophage migration inhibitory factor in myocardial ischaemia/reperfusion injury
Rassaf, T., Weber, C., & Bernhagen, J. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu071 · Cited by 84
Zhang, X., Yeung, E., Wang, J., Panzhinskiy, E., Tong, C., Li, W., & Li, J. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05395.x · Cited by 83
Self-citationFagone, P., Mazzon, E., Cavalli, E., Bramanti, A., Petralia, M. C., Mangano, K., Al‐Abed, Y., Bramati, P., & Nicoletti, F. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.009 · Cited by 81
Macrophage Migration Inhibitory Factor Deficiency Augments Doxorubicin‐Induced Cardiomyopathy
Xu, X., Bucala, R., & Ren, J. T. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000439 · Cited by 81
Self-citationLeyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.021 · Cited by 80
The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury
Qi, D., Atsina, K. B.-T., Qu, L., Hu, X., Wu, X., Xu, B., Piecychna, M., Leng, L., Fingerle‐Rowson, G., Zhang, J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73061 · Cited by 75
Self-citationMIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics
Tilstam, P. V., Qi, D., Leng, L., Young, L. H., & Bucala, R. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1336227 · Cited by 76
Self-citation
Metadata
- Authors
- Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., & Young, L. H.
- Affiliations
- Yale University (US)
- Hokkaido University (JP)
- Corresponding author
- Young, Lawrence H.
- Venue
- Nature
- Published
- 2008-01
- Volume
- 451
- Issue
- 7178
- Pages
- 578-582
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2039411604
- Cited by
- 429
- References
- 33
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 14 · 2023: 14 · 2022: 18 · 2021: 22 · 2020: 16 · 2019: 30 · 2018: 29 · 2017: 20 · 2016: 26 · 2015: 33 · 2014: 27 · 2013: 38 · 2012: 34
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- macrophage migration inhibitory factor, AMPK, ischemia-reperfusion injury, CD74, glucose uptake, cardioprotection, inflammation, hypoxia, coronary artery disease, autocrine and paracrine signaling, energy metabolism
- MeSH terms
- Animals, Hypoxia, Antigens, Differentiation, B-Lymphocyte, Histocompatibility Antigens Class II, Coronary Artery Disease, Enzyme Activation, Genotype, Glucose, Humans, Macrophage Migration-Inhibitory Factors, Multienzyme Complexes, Myocardium, Polymorphism, Genetic, Promoter Regions, Genetic, Signal Transduction, Myocardial Reperfusion Injury, Myocardial Ischemia, Protein Serine-Threonine Kinases, Genetic Predisposition to Disease, Mice, Rats, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
